Hidradenitis Suppurativa: Guidelines and Pipelines

Dr. John Frew is a fellow of the Australasian College of Dermatologists and a globally recognized researcher in Hidradenitis Suppurativa. He completed his medical degree (with Honours) from the University of New South Wales in 2009, followed by a Masters of Medicine in clinical epidemiology from the University of Sydney in 2011, followed by completing his dermatology specialist training in 2016. Dr. Frew recently completed a highly competitive post-doctoral fellowship at the prestigious Rockefeller University in New York City between 2018-2020 (under the guidance of Professor James Krueger), identifying immunological pathways and novel therapies for the treatment of Hidradenitis Suppurativa. Dr. Frew has over 100 peer-reviewed publications and contributed to numerous dermatology and immunology textbooks. He currently holds a staff specialist position at Liverpool Hospital and is a conjoint lecturer at the University of New South Wales, supervising dermatology trainees and postgraduate research students.

Dr. Kirby is a dermatologist and clinician-researcher at Penn State Hershey. She earned her Medical degree from the University of Virginia, then completed her Dermatology Residency at the University of Pennsylvania. In her clinical and research work, she is interested in acneiform conditions including acne, rosacea, and, especially, hidradenitis suppurativa – its effects on people, outcome measurement, and pathomechanisms. She is the PI of a number of clinical research trials. All of this is made possible by the support of her husband and two daughters.